Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation

Acta Gastro-Enterologica Belgica

Volumn 68, Issue 3, 2005, Pages 331-336

  Duclos Vallée, Jean Charles ^a,b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CYCLOSPORIN; TACROLIMUS;

AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY SCREENING; AUTOIMMUNE HEPATITIS; CONFERENCE PAPER; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR;

CHOLANGITIS, SCLEROSING; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; RECURRENCE;

EID: 26944444723     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. NEUBERGER J. et al. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation, 1984, 37: 363-5.
2. GÖTZ G. et al. Recurrence of autoimmune hepatitis after liver transplantation. Transpl. Proc., 1999, 31: 430-431.
3. MILKIEWICZ P. et al. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation, 1999, 68: 253-256.
4. REICH D.J. et al. Liver transplantation for autoimmune hepatitis. Hepatology, 2000, 32: 693-700.
5. AYATA G. et al. Liver Transplantation for autoimmune hepatitis: a long-term pathologic study. Hepatology, 2000, 32: 185-192.
6. GONZALEZ-KOCH A, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transplant, 2001, 7: 302-310.
7. DUCLOS-VALLÉE J.C. et al. A ten-year follow-up study of patients transplanted for autoimmune hepatitis: histologic recurrence precedes clinical and biochemical recurrence. Gut, 2003, 52: 893-897.
8. HÜBSCHER S.G. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome. Liver Transpl., 2001, 7: 285-291.
9. PRADOS E. et al. Outcome of autoimmune hepatitis after liver transplantation. Transplantation, 1998, 12: 1645-1650.
10. CZAJA A.J., MANNS M.P. The validity and importance of subtypes in autoimmune hepatitis: A point of view. Am. J. Gastroenterol., 1995, 90: 1206-1211.
11. HURTOVA M. et al. Successful Tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis ina liver graft recipient. Liver Transplant., 2001, 7: 556-8.
12. RATZIU et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J. Hepatol., 1999, 30: 131-141.
13. HENEGHAN M.A. et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology, 2001, 34: 464-470.
14. ANDRIES S. et al. Post transplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation, 2001, 72: 267-272.
15. GUPTA P. et al. De novo hepatitis with autoimmune antibodies and atpical histology. Transplantation, 2001, 71: 664-668.
16. KERKAR N. et al. De-novo autoimmune hepatitis after liver transplantation. Lancet, 1998, 353: 409-413.
17. MOLMENTI E.P. et al. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl., 2002, 8: 519-526.
18. SALCEDO M. et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology, 2002, 35: 349-356.
19. NEUBERGER J. et al. Recurrence of primary biliary cirrhosis after liver transplantation. N. Engl. J. Med., 1982 306: 1-4.
20. POLSON R. et al. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology, 1989, 97: 715-725.
21. HÜBSCHER S. et al. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J. Hepatol., 1993, 18: 173-184.
22. BALAN V. et al. Histological evidence for recurrence after liver transplantation for primary biliary cirrhosis. Gastroenterology, 1989, 97: 715-725.
23. SEBAGH M. et al. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation, 1998, 65: 1328-1333.
24. DUBEL L. et al. Kinetics of anti-M2 antibodies after liver transplantation for PBC. J. Hepatol., 1995, 23: 674-681.
25. VAN DE WATER J. et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology, 1996, 74: 1079-1084.
26. SYLVESTRE P.B. et al. Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history. Liver Transpl., 2003, 9: 1086-1093.
27. ABU-ELMAGD K. et al. Transplantation for primary biliary cirrhosis: recurrence and outcome in 421 patients. Hepatology, 1997, 26: 176A.
28. GARCIA R. et al. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single centre. Hepatology, 2001, 33: 22-27.
29. ADAM R. et al. Evolution of liver transplantation in Europe: Report of the European Liver transplant Registry. Liver Transpl., 2003, 9: 1231-1243.
30. BRANDSTAETER B. et al. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand. J. Gastroenterol., 2003, 38: 1776-1783.
31. NARUMI S. et al. Liver Transplantation for sclerosing cholangitis. Hepatology, 1995, 22: 451-457.
32. GRAZIADEI J.W. et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology, 1999, 30: 1121-1127.
33. SALDEEN K. et al. Follow-up after liver transplantation for primary sclerosing cholangitis: effect on survival, quality of live and colitis. Scand. J. Gastroenterol., 1999, 34: 535-540.
34. WIESNER R.H. Liver transplantation for primary sclerosing cholangtis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Pract. Res. Clin. Gastro, 2001, 15: 667-680.
35. SHENG R. et al. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. Am. J. Roentgen., 1996, 166: 1109-1113.
36. JEYARAH D.R. et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation, 1998, 66: 1300-1306.
37. KUBOTA T. et al. Clinicopathologic findings of recurrent primary sclerosing cholangitis after orthotopic liver transplantation. J. Hepatobiliary Pancreat. Surg., 1999, 6: 377-381.
38. LIDEN H. et al. Liver transplantation for primary sclerosing cholangitis-a single center experience. Transpl. Int., 2000, 13: S162-S164.
39. YUSOFF I.F. et al. Disease recurrence after liver transplantation in Western Australia. J. Gastroenterol. Hepatol., 2002, 17: 203-207.
40. KUGELMAS M. et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl., 2003, 9: 727-732.
41. KHETTRY U. et al. Liver transplantation for primary sclerosing cholangitis: a long term clinicopathologic study. Hum. Pathol., 2003, 34: 1127-1136.
42. LERUT J. et al. Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection. Transpl. Int., 1988, 1: 127-130.
43. MC DONALD V. et al. Biliary strictures in hepatic transplantation. J. Vasc. Interv. Radiol., 1991; 2: 533-538.
44. HARRISON R.F. et al. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology, 1994, 20: 356-361.
45. GRAZIADEI J.W. et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology, 1999, 30: 1121-1127.
46. DUCLOS-VALLÉE J.C. et al. Value of imaging findings in the detection of recurrent primary sclerosing cholangitis after liver orthotopic transplantation. J. Hepatol., 2004, 40: Suppl. 1, Abstract 125.
47. VERA A. et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet, 2002, 360: 1943-1944.
48. NARUMI S. et al. Liver Transplantation for sclerosing cholangitis. Hepatology, 1995, 22: 451-457.
49. GOSS J. et al. Orthotopic liver transplantation for primary sclerosing cholangitis: a 12-year single center experience. Ann. Surg., 1997, 225: 472-481.